Peter Speelman
Impact in
-
- Antibiotic Use and Resistance
- Endocrinology top 0.5%
Papers in
-
- Tuberculosis Research and Epidemiology 13
-
- Legionella and Acanthamoeba research 7
- Co-authors
- Ed J. Kuijper (19 shared papers)Tom van der Poll (44 shared papers)Sander J. H. van Deventer (38 shared papers)Jan M. Prins (28 shared papers)Els van Nood (6 shared papers)Josbert J. Keller (5 shared papers)Max Nieuwdorp (3 shared papers)Joep F.W.M. Bartelsman (3 shared papers)
- Journals
- The Journal of Infectious Diseases (18 papers)Clinical Infectious Diseases (8 papers)Infection and Immunity (8 papers)Antimicrobial Agents and Chemotherapy (7 papers)European Journal of Clinical Microbiology & Infectious Diseases (6 papers)
- Partner nations
- NetherlandsUnited StatesBangladesh
In The Last Decade
Peter Speelman
138 papers receiving 9.1k citations
Peter Speelman's Hit Papers
Peers
Comparison fields: 5 of 144
- Applied Microbiology and Biotechnology 355
- Endocrinology 599
- Infectious Diseases 2.3k
- Immunology 940
- Epidemiology 1.4k
Countries citing papers authored by Peter Speelman
This map shows the geographic impact of Peter Speelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Speelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Speelman more than expected).
Fields of papers citing papers by Peter Speelman
This network shows the impact of papers produced by Peter Speelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Speelman. The network helps show where Peter Speelman may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Speelman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 144 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile Hit paper breakdown → | 2013 | 3033 |
| 2 | 1993 | 295 | |
| 3 | 2006 | 256 | |
| 4 | 2000 | 235 | |
| 5 | 2002 | 224 | |
| 6 | 2004 | 209 | |
| 7 | 1999 | 196 | |
| 8 | 2002 | 154 | |
| 9 | 1999 | 146 | |
| 10 | 2010 | 143 | |
| 11 | 1999 | 134 | |
| 12 | 1994 | 131 | |
| 13 | 2001 | 109 | |
| 14 | 1994 | 108 | |
| 15 | 1995 | 100 | |
| 16 | 2002 | 95 | |
| 17 | 1985 | 94 | |
| 18 | 1995 | 94 | |
| 19 | 1984 | 92 | |
| 20 | 2008 | 92 |
About Peter Speelman
Peter Speelman is a scholar working on Infectious Diseases, Endocrinology, Epidemiology, Immunology and Parasitology, having authored 144 papers that have together received 9.7k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (16 papers), Immune Response and Inflammation (15 papers), Tuberculosis Research and Epidemiology (13 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers), Sepsis Diagnosis and Treatment (9 papers), Inflammation biomarkers and pathways (7 papers), Legionella and Acanthamoeba research (7 papers) and Chemokine receptors and signaling (7 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (355 citations), Endocrinology (599 citations), Infectious Diseases (2.3k citations), Immunology (940 citations) and Epidemiology (1.4k citations). Peter Speelman has collaborated with scholars based in Netherlands, United States and Bangladesh. Frequent co-authors include Ed J. Kuijper, Tom van der Poll, Sander J. H. van Deventer, Jan M. Prins, Els van Nood, Josbert J. Keller, Max Nieuwdorp, Joep F.W.M. Bartelsman, Caroline Elisabeth Visser and Susana Fuentes. Their work appears in journals such as The Journal of Infectious Diseases, Clinical Infectious Diseases, Infection and Immunity, Antimicrobial Agents and Chemotherapy and European Journal of Clinical Microbiology & Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.